دورية أكاديمية

Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study

التفاصيل البيبلوغرافية
العنوان: Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study
المؤلفون: Palomba, Maria Lia, Cartron, Guillaume, Popplewell, Leslie, Ribrag, Vincent, Westin, Jason, Huw, Ling-Yuh, Agarwal, Shefali, Shivhare, Mahesh, Hong, Wan-Jen, Raval, Aparna, Chang, Alice C., Penuel, Elicia, Morschhauser, Franck
المصدر: In Clinical Lymphoma, Myeloma and Leukemia July 2022 22(7):504-512
قاعدة البيانات: ScienceDirect
الوصف
تدمد:21522650
DOI:10.1016/j.clml.2021.12.014